LIFECORE BIOMEDICAL, INC. Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)
LIFECORE BIOMEDICAL, INC. (LFCR) reported Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) of $0 for the 12-month period ending 2023-05-28, per its 10-K filed 2024-03-20.
Discontinued › Income Statement › Other Income
us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2024-03-20
- LIFECORE BIOMEDICAL, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for the quarter ending 2022-05-29 was $0.00, a 100.00% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for the quarter ending 2022-02-27 was $0.00.
- LIFECORE BIOMEDICAL, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for the quarter ending 2021-05-30 was $331.00K.
- LIFECORE BIOMEDICAL, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for the quarter ending 2021-02-28 was $0.00.
- LIFECORE BIOMEDICAL, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for fiscal 2023 was $0.00.
- LIFECORE BIOMEDICAL, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for fiscal 2022 was $0.00.
- LIFECORE BIOMEDICAL, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for fiscal 2021 was -$11.47M.
- LIFECORE BIOMEDICAL, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for fiscal 2020 was -$4.20M, a 362.50% decline from fiscal 2019.
| Period end | Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) 3 month | Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) 6 month | Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) 9 month | Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) 12 month | Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2023-05-28 | $0.00 10-K · filed 2024-03-20 | ||||
| 2022-05-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $0.00 derived: sum of 2 quarters · filed 2024-03-20 | $0.00 10-K · filed 2024-03-20 | ||
| 2022-02-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-07 | $0.00 10-Q · filed 2022-04-07 | |||
| 2021-11-28 | $0.00 10-Q · filed 2022-01-07 | ||||
| 2021-05-30 | $331.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | $331.00K derived: sum of 2 quarters · filed 2024-03-20 | -$11.47M 10-K · filed 2024-03-20 | -$11.80M 10-K · filed 2021-07-29 | |
| 2021-02-28 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2024-03-20 | -$11.80M 10-K · filed 2024-03-20 | |||
| 2020-11-29 | -$11.80M 10-Q · filed 2022-01-07 | ||||
| 2020-05-31 | -$4.40M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | -$4.40M derived: sum of 2 quarters · filed 2023-03-16 | -$4.20M derived: sum of 3 quarters · filed 2023-03-16 | -$4.20M 10-K/A · filed 2023-03-16 | |
| 2020-02-23 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | $200.00K derived: sum of 2 quarters · filed 2021-04-08 | $200.00K 10-Q · filed 2021-04-08 | $200.00K derived: sum of 4 quarters · filed 2021-07-29 | |
| 2019-11-24 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | $200.00K 10-Q · filed 2021-01-07 | $200.00K derived: sum of 3 quarters · filed 2021-07-29 | $200.00K derived: sum of 4 quarters · filed 2021-07-29 | |
| 2019-08-25 | $0.00 10-Q · filed 2019-10-03 | $0.00 derived: sum of 2 quarters · filed 2021-07-29 | $0.00 derived: sum of 3 quarters · filed 2021-07-29 | $600.00K derived: sum of 4 quarters · filed 2021-07-29 | |
| 2019-05-26 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $0.00 derived: sum of 2 quarters · filed 2021-07-29 | $600.00K derived: sum of 3 quarters · filed 2021-07-29 | $1.60M 10-K · filed 2021-07-29 | |
| 2019-02-24 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $600.00K derived: sum of 2 quarters · filed 2020-04-03 | $1.60M 10-Q · filed 2020-04-03 | $2.30M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2018-11-25 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | $1.60M 10-Q · filed 2020-01-02 | $2.30M derived: sum of 3 quarters · filed 2020-08-14 | $2.30M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2018-08-26 | $1.00M 10-Q · filed 2019-10-03 | $1.70M derived: sum of 2 quarters · filed 2020-08-14 | $1.70M derived: sum of 3 quarters · filed 2020-08-14 | $3.00M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2018-05-27 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $700.00K derived: sum of 2 quarters · filed 2020-08-14 | $2.00M derived: sum of 3 quarters · filed 2020-08-14 | $2.90M 10-K · filed 2020-08-14 | |
| 2018-02-25 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04 | $1.30M derived: sum of 2 quarters · filed 2019-04-04 | $2.20M 10-Q · filed 2019-04-04 | $2.40M derived: sum of 4 quarters · filed 2019-08-01 | |
| 2017-11-26 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07 | $2.20M 10-Q · filed 2019-01-07 | $2.40M derived: sum of 3 quarters · filed 2019-08-01 | ||
| 2017-08-27 | $900.00K 10-Q · filed 2018-10-05 | $1.10M derived: sum of 2 quarters · filed 2019-08-01 | |||
| 2017-05-28 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | $900.00K 10-K · filed 2019-08-01 | |||
| 2017-02-26 | $700.00K 10-Q · filed 2018-04-05 | ||||
| 2016-05-29 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | $200.00K derived: sum of 2 quarters · filed 2018-08-09 | $400.00K derived: sum of 3 quarters · filed 2018-08-09 | $1.20M 10-K · filed 2018-08-09 | |
| 2016-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07 | $200.00K derived: sum of 2 quarters · filed 2017-04-07 | $1.00M 10-Q · filed 2017-04-07 | $1.40M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2015-11-29 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05 | $1.00M 10-Q · filed 2017-01-05 | $1.40M derived: sum of 3 quarters · filed 2018-03-15 | $3.50M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2015-08-30 | $800.00K 10-Q · filed 2016-09-29 | $1.20M derived: sum of 2 quarters · filed 2018-03-15 | $3.30M derived: sum of 3 quarters · filed 2018-03-15 | $4.50M derived: sum of 4 quarters · filed 2018-03-15 | |
| 2015-05-31 | $400.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | $2.50M derived: sum of 2 quarters · filed 2018-03-15 | $3.70M derived: sum of 3 quarters · filed 2018-03-15 | $3.90M 10-K/A · filed 2018-03-15 | |
| 2015-03-01 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | $3.30M derived: sum of 2 quarters · filed 2016-03-30 | $3.50M 10-Q · filed 2016-03-30 | $5.40M derived: sum of 4 quarters · filed 2016-08-01 | |
| 2014-11-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07 | $1.40M 10-Q · filed 2016-01-07 | $3.30M derived: sum of 3 quarters · filed 2016-08-01 | $3.70M derived: sum of 4 quarters · filed 2016-08-01 | |
| 2014-08-31 | $200.00K 10-Q · filed 2015-10-01 | $2.10M derived: sum of 2 quarters · filed 2016-08-01 | $2.50M derived: sum of 3 quarters · filed 2016-08-01 | $4.80M derived: sum of 4 quarters · filed 2016-08-01 | |
| 2014-05-25 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $2.30M derived: sum of 2 quarters · filed 2016-08-01 | $4.60M derived: sum of 3 quarters · filed 2016-08-01 | $10.00M 10-K · filed 2016-08-01 | |
| 2014-02-23 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | $2.70M derived: sum of 2 quarters · filed 2015-04-02 | $8.10M 10-Q · filed 2015-04-02 | $9.90M derived: sum of 4 quarters · filed 2015-07-31 | |
| 2013-11-24 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | $7.70M 10-Q · filed 2015-01-09 | $9.50M derived: sum of 3 quarters · filed 2015-07-31 | $10.55M derived: sum of 4 quarters · filed 2015-07-31 | |
| 2013-08-25 | $5.40M 10-Q · filed 2014-10-08 | $7.20M derived: sum of 2 quarters · filed 2015-07-31 | $8.25M derived: sum of 3 quarters · filed 2015-07-31 | $9.20M derived: sum of 4 quarters · filed 2015-07-31 | |
| 2013-05-26 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $2.85M derived: sum of 2 quarters · filed 2015-07-31 | $3.80M derived: sum of 3 quarters · filed 2015-07-31 | $8.10M 10-K · filed 2015-07-31 | |
| 2013-02-24 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | $2.00M derived: sum of 2 quarters · filed 2014-03-28 | $6.30M 10-Q · filed 2014-03-28 | ||
| 2012-11-25 | $956.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | $5.25M 10-Q · filed 2014-01-03 | |||
| 2012-08-26 | $4.30M 10-Q · filed 2013-09-26 | ||||
| 2012-05-27 | $5.84M 10-K · filed 2014-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |